Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 24 | 2016 | 410 | 2.000 |
Why?
|
| Puerto Rico | 25 | 2016 | 1376 | 0.530 |
Why?
|
| Integrons | 1 | 2015 | 1 | 0.480 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2015 | 34 | 0.470 |
Why?
|
| Genetic Variation | 2 | 2015 | 429 | 0.470 |
Why?
|
| Escherichia coli Infections | 1 | 2015 | 43 | 0.460 |
Why?
|
| Escherichia coli | 1 | 2015 | 461 | 0.380 |
Why?
|
| Child | 23 | 2016 | 3381 | 0.380 |
Why?
|
| Anxiety Disorders | 2 | 2012 | 319 | 0.360 |
Why?
|
| Depressive Disorder | 1 | 2012 | 185 | 0.330 |
Why?
|
| Capacity Building | 4 | 2015 | 99 | 0.320 |
Why?
|
| Allergens | 3 | 2014 | 64 | 0.310 |
Why?
|
| Vitamin D Deficiency | 3 | 2016 | 107 | 0.300 |
Why?
|
| Obesity | 3 | 2013 | 1131 | 0.280 |
Why?
|
| Adolescent | 20 | 2016 | 5950 | 0.270 |
Why?
|
| Dust | 3 | 2014 | 55 | 0.230 |
Why?
|
| Hypersensitivity | 2 | 2016 | 32 | 0.220 |
Why?
|
| Violence | 2 | 2016 | 133 | 0.220 |
Why?
|
| Bronchodilator Agents | 3 | 2016 | 26 | 0.180 |
Why?
|
| Logistic Models | 6 | 2016 | 1001 | 0.180 |
Why?
|
| Vital Capacity | 3 | 2016 | 44 | 0.170 |
Why?
|
| Case-Control Studies | 8 | 2016 | 1266 | 0.170 |
Why?
|
| Humans | 29 | 2016 | 42163 | 0.170 |
Why?
|
| Male | 22 | 2016 | 22779 | 0.170 |
Why?
|
| Body Mass Index | 3 | 2013 | 916 | 0.160 |
Why?
|
| Female | 21 | 2016 | 24018 | 0.150 |
Why?
|
| Immunoglobulin E | 2 | 2016 | 59 | 0.150 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 2 | 2015 | 4 | 0.140 |
Why?
|
| Community-Based Participatory Research | 2 | 2014 | 336 | 0.140 |
Why?
|
| Severity of Illness Index | 4 | 2016 | 708 | 0.140 |
Why?
|
| Cities | 2 | 2015 | 78 | 0.140 |
Why?
|
| Genome-Wide Association Study | 3 | 2015 | 421 | 0.130 |
Why?
|
| Folic Acid Deficiency | 1 | 2016 | 6 | 0.120 |
Why?
|
| Firearms | 1 | 2016 | 16 | 0.120 |
Why?
|
| Genotype | 2 | 2015 | 796 | 0.120 |
Why?
|
| Disk Diffusion Antimicrobial Tests | 1 | 2015 | 1 | 0.120 |
Why?
|
| Weapons | 1 | 2015 | 5 | 0.120 |
Why?
|
| Multivariate Analysis | 5 | 2016 | 638 | 0.120 |
Why?
|
| Interleukin-17 | 1 | 2015 | 53 | 0.120 |
Why?
|
| Education, Public Health Professional | 1 | 2015 | 19 | 0.120 |
Why?
|
| Cluster Analysis | 1 | 2015 | 206 | 0.110 |
Why?
|
| Quantitative Trait Loci | 1 | 2015 | 88 | 0.110 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 74 | 0.110 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2014 | 11 | 0.110 |
Why?
|
| DNA, Bacterial | 1 | 2015 | 207 | 0.110 |
Why?
|
| Hospitals | 1 | 2015 | 115 | 0.110 |
Why?
|
| Mexico | 1 | 2015 | 286 | 0.110 |
Why?
|
| Air Pollution, Indoor | 1 | 2014 | 50 | 0.110 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2013 | 5 | 0.110 |
Why?
|
| Academies and Institutes | 1 | 2014 | 39 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 454 | 0.110 |
Why?
|
| Medicine | 1 | 2014 | 37 | 0.110 |
Why?
|
| Evidence-Based Practice | 1 | 2014 | 48 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2015 | 170 | 0.100 |
Why?
|
| Environmental Exposure | 1 | 2016 | 247 | 0.100 |
Why?
|
| Prevalence | 3 | 2014 | 1597 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 508 | 0.100 |
Why?
|
| Health Services Research | 1 | 2014 | 161 | 0.100 |
Why?
|
| Fungi | 1 | 2014 | 103 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2015 | 860 | 0.100 |
Why?
|
| Breast Feeding | 1 | 2014 | 123 | 0.100 |
Why?
|
| Phenotype | 1 | 2015 | 774 | 0.100 |
Why?
|
| Adiposity | 1 | 2013 | 155 | 0.090 |
Why?
|
| Odds Ratio | 4 | 2015 | 587 | 0.090 |
Why?
|
| Premature Birth | 1 | 2013 | 94 | 0.090 |
Why?
|
| Interview, Psychological | 1 | 2012 | 63 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2015 | 461 | 0.090 |
Why?
|
| Residence Characteristics | 1 | 2014 | 359 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2012 | 224 | 0.090 |
Why?
|
| Family | 2 | 2010 | 192 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 727 | 0.090 |
Why?
|
| Caregivers | 2 | 2011 | 195 | 0.090 |
Why?
|
| Health Literacy | 1 | 2013 | 120 | 0.090 |
Why?
|
| Skin Tests | 3 | 2016 | 13 | 0.090 |
Why?
|
| Parents | 1 | 2013 | 359 | 0.080 |
Why?
|
| Young Adult | 4 | 2015 | 4936 | 0.080 |
Why?
|
| Social Class | 1 | 2012 | 286 | 0.080 |
Why?
|
| Depressive Disorder, Major | 1 | 2011 | 128 | 0.080 |
Why?
|
| Diet | 1 | 2015 | 810 | 0.080 |
Why?
|
| Linear Models | 3 | 2015 | 311 | 0.080 |
Why?
|
| Lung | 1 | 2012 | 484 | 0.080 |
Why?
|
| Health Promotion | 1 | 2015 | 691 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2015 | 641 | 0.070 |
Why?
|
| Minority Groups | 1 | 2014 | 663 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2014 | 680 | 0.070 |
Why?
|
| Respiratory Function Tests | 3 | 2013 | 61 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2012 | 541 | 0.070 |
Why?
|
| Sex Factors | 1 | 2012 | 1008 | 0.070 |
Why?
|
| Anxiety | 1 | 2015 | 847 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2012 | 467 | 0.070 |
Why?
|
| Healthcare Disparities | 1 | 2012 | 573 | 0.060 |
Why?
|
| Health Education | 1 | 2010 | 358 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2007 | 234 | 0.060 |
Why?
|
| Forced Expiratory Volume | 2 | 2016 | 75 | 0.060 |
Why?
|
| Cross-Sectional Studies | 4 | 2015 | 3077 | 0.060 |
Why?
|
| Adult | 4 | 2015 | 13458 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2010 | 959 | 0.050 |
Why?
|
| Socioeconomic Factors | 3 | 2016 | 1221 | 0.050 |
Why?
|
| Risk Factors | 3 | 2015 | 3942 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2013 | 1516 | 0.050 |
Why?
|
| Vitamin D | 2 | 2016 | 196 | 0.050 |
Why?
|
| Program Evaluation | 2 | 2015 | 358 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 2 | 2014 | 225 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2015 | 1586 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2015 | 2485 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2016 | 92 | 0.030 |
Why?
|
| Folic Acid | 1 | 2016 | 49 | 0.030 |
Why?
|
| Albuterol | 1 | 2015 | 10 | 0.030 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2015 | 12 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 62 | 0.030 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 19 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2016 | 123 | 0.030 |
Why?
|
| Rhode Island | 1 | 2015 | 17 | 0.030 |
Why?
|
| Dairy Products | 1 | 2015 | 34 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2015 | 36 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2015 | 19 | 0.030 |
Why?
|
| Organizational Case Studies | 1 | 2015 | 31 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2015 | 35 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2015 | 146 | 0.030 |
Why?
|
| Transportation | 1 | 2014 | 27 | 0.030 |
Why?
|
| Endotoxins | 1 | 2014 | 18 | 0.030 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2014 | 7 | 0.030 |
Why?
|
| Pyroglyphidae | 1 | 2014 | 4 | 0.030 |
Why?
|
| Vegetables | 1 | 2015 | 145 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 201 | 0.030 |
Why?
|
| Science | 1 | 2014 | 23 | 0.030 |
Why?
|
| Fruit | 1 | 2015 | 178 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2013 | 34 | 0.030 |
Why?
|
| Air Pollution | 1 | 2014 | 87 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2013 | 90 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2015 | 318 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2015 | 452 | 0.030 |
Why?
|
| Disease Progression | 1 | 2016 | 661 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2014 | 154 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2013 | 134 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 154 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 438 | 0.020 |
Why?
|
| CpG Islands | 1 | 2013 | 107 | 0.020 |
Why?
|
| Proteins | 1 | 2015 | 383 | 0.020 |
Why?
|
| Educational Status | 1 | 2014 | 335 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2014 | 180 | 0.020 |
Why?
|
| Animals | 3 | 2014 | 16695 | 0.020 |
Why?
|
| Mice | 2 | 2014 | 6490 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1054 | 0.020 |
Why?
|
| Focus Groups | 1 | 2014 | 398 | 0.020 |
Why?
|
| Alleles | 1 | 2013 | 352 | 0.020 |
Why?
|
| Community-Institutional Relations | 1 | 2014 | 208 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 250 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 1051 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 960 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 508 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 1143 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 236 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1265 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 274 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 1729 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1066 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2011 | 428 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2013 | 393 | 0.020 |
Why?
|
| Cultural Competency | 1 | 2010 | 137 | 0.020 |
Why?
|
| Comorbidity | 1 | 2011 | 725 | 0.020 |
Why?
|
| Pregnancy | 1 | 2013 | 1737 | 0.020 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2007 | 45 | 0.020 |
Why?
|
| Culture | 1 | 2007 | 172 | 0.020 |
Why?
|
| United States | 1 | 2016 | 5072 | 0.010 |
Why?
|
| Poverty | 1 | 2007 | 395 | 0.010 |
Why?
|
| Health Status Disparities | 1 | 2010 | 705 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 7982 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 11819 | 0.010 |
Why?
|